The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses.

Clicks: 388
ID: 61173
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #11 of 68 articles by views in Cancers

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Expression of TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) by immune cells can lead to the induction of apoptosis in tumor cells. However, it becomes increasingly clear that the interaction of TRAIL and its death receptors (DRs) can also directly impact immune cells and influence immune responses. Here, we review what is known about the role of TRAIL/DRs in immune cells and immune responses in general and in the tumor microenvironment in particular.
Reference Key
sag2019thecancers Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sag, Duygu;Ayyildiz, Zeynep Ozge;Gunalp, Sinem;Wingender, Gerhard;
Journal Cancers
Year 2019
DOI
E1469
URL
Keywords
apoptosis tumor immune regulation lymphoid cells myeloid cells

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.